RiverVest Venture Fund IV, L.P.'s Form 4 filing
Xilio Therapeutics, Inc. (XLO) · filed Oct 26, 2021
- Accession no.
- 0000899243-21-041580
- Filed
- Oct 26, 2021
- Trade date
- Oct 26, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $4.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RiverVest Venture Fund IV, L.P.CIK 0001725443 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionAcquired | +832,120 | – | – | 832,120 | Indirect | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +359,324 | – | – | 1,191,444 | Indirect | |
| Oct 26, 2021 | Common Stock | PPurchaseAcquired | +250,000 | $16.00 | +$4,000,000 | 1,441,444 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionDisposed | −832,120 | $0.00 | $0 | 0 | Indirect | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −359,324 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.